Literature DB >> 14653411

The changing epidemiology of esophageal adenocarcinoma.

Jeffrey T Wei1, NicholasJ Shaheen.   

Abstract

The incidence of esophageal adenocarcinoma has risen rapidly over the past 3 decades. This increase had been most dramatic among white men. It has supplanted squamous cell carcinoma as the predominant histologic type of esophageal cancer in the United States. The reasons underlying this phenomenon are not readily apparent. Improvements in diagnostic techniques and changes in cancer classification may explain some of the rise in reported incidence rates, but detection bias and misclassification bias do not appear adequate to explain the increase entirely. Risk factors for esophageal adenocarcinoma are reviewed, with particular emphasis on their role in underlying the rising cancer incidence. The etiologic factors most likely to explain the current epidemic of esophageal adenocarcinoma are the parallel epidemic of obesity, rising use of lower esophageal sphincter-relaxing medications, decreasing Helicobacter pylori infection, changes in the Western diet, and distant smoking habits.

Entities:  

Mesh:

Year:  2003        PMID: 14653411

Source DB:  PubMed          Journal:  Semin Gastrointest Dis        ISSN: 1049-5118


  9 in total

Review 1.  Endoscopic therapy for Barrett's oesophagus.

Authors:  H Barr; N Stone; B Rembacken
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

2.  Increasing incidence of Barrett's oesophagus: a population-based study.

Authors:  Helen G Coleman; Shivaram Bhat; Liam J Murray; Damian McManus; Anna T Gavin; Brian T Johnston
Journal:  Eur J Epidemiol       Date:  2011-06-14       Impact factor: 8.082

Review 3.  Endoscopic screening and surveillance for Barrett's esophagus--clinical implications.

Authors:  Hugh Barr; Catherine Kendall; Florain Bazant-Hegemark; Paul Moayyedi; G Shetty; Nicholas Stone
Journal:  MedGenMed       Date:  2006-06-27

4.  Polymorphism Arg290Arg in esophageal-cancer-related gene 1 (ECRG1) is a prognostic factor for survival in esophageal cancer.

Authors:  Kai Bachmann; Shanly Shahmiri; Jussuf Kaifi; Paulus Schurr; Oliver Mann; Tamina Rawnaq; Suzette Block; Viacheslav Kalinin; Jakob R Izbicki; Tim Strate
Journal:  J Gastrointest Surg       Date:  2008-12-04       Impact factor: 3.452

5.  A 52-year-old man with heartburn: should he undergo screening for Barrett's esophagus?

Authors:  Seth D Crockett; A Sidney Barritt; Nicholas J Shaheen
Journal:  Clin Gastroenterol Hepatol       Date:  2009-12-03       Impact factor: 11.382

6.  Genetics in the pathogenesis of esophageal cancer: possible predictive and prognostic factors.

Authors:  Daniel Vallböhmer; Jan Brabender; Ralf Metzger; Arnulf H Hölscher
Journal:  J Gastrointest Surg       Date:  2009-09-12       Impact factor: 3.452

7.  Epidemiological investigation of esophageal carcinoma.

Authors:  Hong Zhang; Shao-Hua Chen; You-Ming Li
Journal:  World J Gastroenterol       Date:  2004-06-15       Impact factor: 5.742

8.  Trends in esophageal cancer and body mass index by race and gender in the state of Michigan.

Authors:  Eric J Kort; Eric Sevensma; Timothy L Fitzgerald
Journal:  BMC Gastroenterol       Date:  2009-06-23       Impact factor: 3.067

9.  Insulin/Insulin-Like Growth Factor-1 Pathway in Barrett's Carcinogenesis.

Authors:  K B Greer; A Kresak; B Bednarchik; D Dawson; L Li; A Chak; J Willis
Journal:  Clin Transl Gastroenterol       Date:  2013-03-07       Impact factor: 4.488

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.